The impact of language discordance on pediatric cancer care outcomes: A systematic review.
communication
health disparities
language discordance
pediatric cancer
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
25 Sep 2024
25 Sep 2024
Historique:
revised:
23
08
2024
received:
30
06
2024
accepted:
09
09
2024
medline:
26
9
2024
pubmed:
26
9
2024
entrez:
26
9
2024
Statut:
aheadofprint
Résumé
Language discordance between clinicians and families in pediatrics has been associated with adverse events and lower quality of care. We aimed to summarize the existing literature evaluating the impact of language discordance among healthcare professionals and families within pediatric oncology by conducting a systematic review. Of 8364 studies, 43 studies met eligibility for inclusion in this review. These studies highlight the impact of language discordance on pediatric cancer care outcomes, including communication challenges, obstacles to research participation, and potentially higher risk disease features at presentation. Healthcare professionals endorsed inconsistent professional interpreter use and lack of formal training on communicating via interpreters. Interventions to address barriers to language-appropriate care are sparse. Further research is warranted to design and implement interventions promoting language justice and provision of high-quality, equitable pediatric cancer care for all families.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e31338Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Why we ask questions about language spoken at home. United States Census Bureau. Accessed April 15, 2024. https://www.census.gov/acs/www/about/why‐we‐ask‐each‐question/language/
Kerfeld CI, Hoffman JM, Ciol MA, Kartin D. Delayed or forgone care and dissatisfaction with care for children with special health care needs: the role of perceived cultural competency of health care providers. Matern Child Health J. 2011;15(4):487‐496.
Ngui EM, Flores G. Satisfaction with care and ease of using health care services among parents of children with special health care needs: the roles of race/ethnicity, insurance, language, and adequacy of family‐centered care. Pediatrics. 2006;117(4):1184‐1196.
Inkelas M, Garro N, McQuaid EL, Ortega AN. Race/ethnicity, language, and asthma care: findings from a 4‐state survey. Ann Allergy Asthma Immunol. 2008;100(2):120‐127.
Blumberg SJ, Read D, Avila RM, Bethell CD. Hispanic children with special health care needs from Spanish‐language households. Pediatrics. 2010;126(Suppl 3):S120‐S128.
Read D, Bethell C, Blumberg SJ, Abreu M, Molina C. An evaluation of the linguistic and cultural validity of the Spanish language version of the children with special health care needs screener. Matern Child Health J. 2007;11(6):568‐585.
Foster BA, Read D, Bethell C. An analysis of the association between parental acculturation and children's medication use. Pediatrics. 2009;124(4):1152‐1161.
Cohen AL, Rivara F, Marcuse EK, McPhillips H, Davis R. Are language barriers associated with serious medical events in hospitalized pediatric patients. Pediatrics. 2005;116(3):575‐579.
Flores G, Rabke‐Verani J, Pine W, Sabharwal A. The importance of cultural and linguistic issues in the emergency care of children. Pediatr Emerg Care. 2002;18(4):271‐284.
Eneriz‐Wiemer M, Sanders LM, Barr DA, Mendoza FS. Parental limited English proficiency and health outcomes for children with special health care needs: a systematic review. Acad Pediatr. 2014;14(2):128‐136.
Forray AI, Oltean O, Hanft‐Robert S, et al. Uncovering multi‐level mental healthcare barriers for migrants: a qualitative analysis across China, Germany, Netherlands, Romania, and South Africa. BMC Public Health. 2024;24(1):1593.
Brandenberger J, Tylleskär T, Sontag K, Peterhans B, Ritz N. A systematic literature review of reported challenges in health care delivery to migrants and refugees in high‐income countries—the 3C model. BMC Public Health. 2019;19(1):755.
Sisk BA, Harvey K, Friedrich AB, et al. Multilevel barriers and facilitators of communication in pediatric oncology: a systematic review. Pediatr Blood Cancer. 2022;69(1):e29405.
Divi C, Koss RG, Schmaltz SP, Loeb JM. Language proficiency and adverse events in US hospitals: a pilot study. Int J Qual Health Care. 2007;19(2):60‐67.
Jacobs ZG, Prasad PA, Fang MC, Abe‐Jones Y, Kangelaris KN. The association between limited English proficiency and sepsis mortality. J Hosp Med. 2020;15(3):140‐146.
Higgins JPTTJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.4. Cochrane; 2023.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583.
Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. University of Alberta; 2004. Accessed June 16, 2024. https://era.library.ualberta.ca/items/48b9b989‐c221‐4df6‐9e35‐af782082280e
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276‐282.
Lee L, Packer TL, Tang SH, Girdler S. Self‐management education programs for age‐related macular degeneration: a systematic review. Australas J Ageing. 2008;27(4):170‐176.
Lim YH, Licari M, Spittle AJ, et al. Early motor function of children with autism spectrum disorder: a systematic review. Pediatrics. 2021;147(2):e2020011270.
Green AL, Chintagumpala M, Krailo M, et al. Correlation of insurance, race, and ethnicity with pathologic risk in a controlled retinoblastoma cohort: a Children's Oncology Group study. Ophthalmology. 2016;123(8):1817‐1823.
Morshed N, Zhan FB. Racial/ethnic, social characteristics and geographic disparities of childhood cancer late‐stage diagnosis in Texas, 2005 to 2014. Ann Gis. 2021;27(4):329‐340.
Truong B, Green AL, Friedrich P, Ribeiro KB, Rodriguez‐Galindo C. Ethnic, racial, and socioeconomic disparities in retinoblastoma. JAMA Pediatr. 2015;169(12):1096‐1104.
Gruszczynski NR, Low CM, Choby G, Meister KD, Smith BH, Balakrishnan K. Effects of social determinants of health care on pediatric thyroid cancer outcomes in the United States. Otolaryngol Head Neck Surg. 2022;166(6):1045‐1054.
Patel SK, Mullins W, Turk A, Dekel N, Kinjo C, Sato JK. Distress screening, rater agreement, and services in pediatric oncology. Psychooncology. 2011;20(12):1324‐1333.
Tobin J, Miller KA, Baezconde‐Garbanati L, Unger JB, Hamilton AS, Milam JE. Acculturation, mental health, and quality of life among hispanic childhood cancer survivors: a latent class analysis. Ethn Dis. 2018;28(1):55‐60.
Bava L, Freyer DR, Radbill LM, Johns AL. Association of language proficiency, sociodemographics, and neurocognitive functioning in dual‐language Latino survivors of childhood acute lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer. 2021;68(9):e29118.
Brock KE, Steineck A, Twist CJ. Trends in end‐of‐life care in pediatric hematology, oncology, and stem cell transplant patients. Pediatr Blood Cancer. 2016;63(3):516‐522.
Jacob E, McCarthy KS, Sambuco G, Hockenberry M. Intensity, location, and quality of pain in Spanish‐speaking children with cancer. Pediatr Nurs. 2008;34(1):45‐52.
Noyd DH, Berkman A, Howell C, et al. Leveraging clinical informatics tools to extract cumulative anthracycline exposure, measure cardiovascular outcomes, and assess guideline adherence for children with cancer. JCO Clin Cancer Inform. 2021;5:1062‐1075.
Robles JM, Troy JD, Schroeder KM, Martin PL, LeBlanc TW. Parental limited English proficiency in pediatric stem cell transplantation: clinical impact and health care utilization. Pediatr Blood Cancer. 2021;68(9):e29174.
Zamora ER, Kaul S, Kirchhoff AC, et al. The impact of language barriers and immigration status on the care experience for Spanish‐speaking caregivers of patients with pediatric cancer. Pediatr Blood Cancer. 2016;63(12):2173‐2180.
Aristizabal P, Singer J, Cooper R, et al. Participation in pediatric oncology research protocols: racial/ethnic, language and age‐based disparities. Pediatr Blood Cancer. 2015;62(8):1337‐1344.
Aristizabal P, Ma AK, Kumar NV, et al. Assessment of factors associated with parental perceptions of voluntary decisions about child participation in leukemia clinical trials. JAMA Netw Open. 2021;4(5):e219038.
Lewin J, Bell JAH, Wang K, et al. Evaluation of adolescents' and young adults' attitudes toward participation in cancer clinical trials. JCO Oncol Pract. 2020;16(3):e280‐e289.
Russo C, Stout L, House T, Santana VM. Barriers and facilitators of clinical trial enrollment in a network of community‐based pediatric oncology clinics. Pediatr Blood Cancer. 2020;67(4):e28023.
Scollon S, Bergstrom K, Kerstein RA, et al. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med. 2014;6(9):69.
Abbe M, Simon C, Angiolillo A, Ruccione K, Kodish ED. A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents. Pediatr Blood Cancer. 2006;47(6):819‐824.
Barrera M, Alexander S, Shama W, Mills D, Desjardins L, Hancock K. Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers. Pediatr Blood Cancer. 2018;65(12):e27429.
Beckstrand RL, Rawle NL, Callister L, Mandleco BL. Pediatric nurses' perceptions of obstacles and supportive behaviors in end‐of‐life care. Am J Crit Care. 2010;19(6):543‐552.
Chiu HH, Dimaras H, Downie R, Gallie B. Breaking down barriers to communicating complex retinoblastoma information: can graphics be the solution. Can J Ophthalmol. 2015;50(3):230‐235.
Drotar D, Miller V, Willard V, Anthony K, Kodish E. Correlates of parental participation during informed consent for randomized clinical trials in the treatment of childhood leukemia. Ethics Behav. 2004;14(1):1‐15. doi:10.1207/s15327019eb1401_1
Gulati S, Watt L, Shaw N, et al. Communication and language challenges experienced by Chinese and South Asian immigrant parents of children with cancer in Canada: implications for health services delivery. Pediatr Blood Cancer. 2012;58(4):572‐578.
Idossa L, Mau LW, Ferguson SS, Denzen E, Murphy E, Moore H. Access to linguistically appropriate information for blood and marrow transplant patients: results from transplant center staff survey. J Cancer Educ. 2019;34(5):1031‐1037.
Johns AL, Oland AA, Katz ER, et al. Qualitative analysis of the role of culture in coping themes of Latina and European American mothers of children with cancer. J Pediatr Oncol Nurs. 2009;26(3):167‐175.
Laronne A, Granek L, Wiener L, Feder‐Bubis P, Golan H. “Some things are even worse than telling a child he is going to die”: pediatric oncology healthcare professionals perspectives on communicating with children about cancer and end of life. Pediatr Blood Cancer. 2022;69(3):e29533.
Lynn C, Quast L, Rogers H, Effinger K, Gilleland‐Marchak J. Systematic review of health literacy in childhood cancer patients, survivors, and their caregivers. J Pediatr Psychol. 2020;45(4):373‐385.
Mack JW, Cronin AM, Kang TI. Decisional regret among parents of children with cancer. J Clin Oncol. 2016;34(33):4023‐4029.
Ochoa CY, Miller KA, Baezconde‐Garbanati L, Slaughter RI, Hamilton AS, Milam JE. Parental cancer‐related information seeking, health communication and satisfaction with medical providers of childhood cancer survivors: differences by race/ethnicity and language preference. J Health Commun. 2021;26(2):83‐91.
Pergert P, Ekblad S, Enskar K, Bjork O. Obstacles to transcultural caring relationships: experiences of health care staff in pediatric oncology. J Pediatr Oncol Nurs. 2007;24(6):314‐328.
Simon C, Zyzanski SJ, Eder M, Raiz P, Kodish ED, Siminoff LA. Groups potentially at risk for making poorly informed decisions about entry into clinical trials for childhood cancer. J Clin Oncol. 2003;21(11):2173‐2178.
Slone JS, Self E, Friedman D, Heiman H. Disparities in pediatric oncology patient education and linguistic resources: results of a national survey of pediatric oncologists. Pediatr Blood Cancer. 2014;61(2):333‐336.
Suurmond J, Lieveld A, van de Wetering M, Schouten‐van Meeteren AYN. Towards culturally competent paediatric oncology care. A qualitative study from the perspective of care providers. Eur J Cancer Care (Engl). 2017;26(6):e12680.
Thienprayoon R, Marks E, Funes M, Martinez‐Puente LM, Winick N, Lee SC. Perceptions of the pediatric hospice experience among English‐ and Spanish‐speaking families. J Palliat Med. 2016;19(1):30‐41.
Waters AR, Zamora ER, Fluchel M, et al. A qualitative inquiry of communication based barriers to the diagnosis of pediatric cancer: perceptions of primarily Spanish‐speaking caregivers. Patient Educ Couns. 2022;105(6):1503‐1509.
Granhagen Jungner J, Tiselius E, Lutzen K, Blomgren K, Pergert P. Creating a meeting point of understanding: interpreters' experiences in swedish childhood cancer care. J Pediatr Oncol Nurs. 2016;33(2):137‐145.
Granhagen Jungner J, Tiselius E, Blomgren K, Lutzen K, Pergert P. Language barriers and the use of professional interpreters: a national multisite cross‐sectional survey in pediatric oncology care. Acta Oncol. 2019;58(7):1015‐1020.
Granhagen Jungner J, Tiselius E, Blomgren K, Lutzen K, Pergert P. The interpreter's voice: carrying the bilingual conversation in interpreter‐mediated consultations in pediatric oncology care. Patient Educ Couns. 2019;102(4):656‐662.
Granhagen Jungner J, Tiselius E, Pergert P. Reasons for not using interpreters to secure patient‐safe communication—a national cross‐sectional study in paediatric oncology. Patient Educ Couns. 2021;104(8):1985‐1992.
Simon CM, Zyzanski SJ, Durand E, Jimenez XF, Kodish ED. Interpreter accuracy and informed consent among Spanish‐speaking families with cancer. J Health Commun. 2006;11(5):509‐522.
Gil S, Hooke MC, Niess D. The limited English proficiency patient family advocate role: fostering respectful and effective care across language and culture in a pediatric oncology setting. J Pediatr Oncol Nurs. 2016;33(3):190‐198.
Murphy D, Kashal P, Quinn GP, Sawczyn KK, Termuhlen AM. Development of a Spanish language fertility educational brochure for pediatric oncology families. J Pediatr Adolesc Gynecol. 2014;27(4):202‐209.
Weiler‐Wichtl LJ, Fohn‐Erhold V, Schlifelner J, et al. TIS—talking in symbols. development of a tool for nonverbal communication after language barriers in pediatric oncology. Klin Padiatr. 2020;232(6):307‐313.
Sisk BA, Friedrich A, Blazin LJ, Baker JN, Mack JW, DuBois J. Communication in pediatric oncology: a qualitative study. Pediatrics. 2020;146(3):e20201193.
Sisk BA, Zavadil JA, Blazin LJ, Baker JN, Mack JW, DuBois JM. Assume it will break: parental perspectives on negative communication experiences in pediatric oncology. JCO Oncol Pract. 2021;17(6):e859‐e871.
Karliner LS, Jacobs EA, Chen AH, Mutha S. Do professional interpreters improve clinical care for patients with limited English proficiency. Health Serv Res. 2007;42(2):727‐754.
Flores G. The impact of medical interpreter services on the quality of health care: a systematic review. Med Care Res Rev. 2005;62(3):255‐299.
Kalet A, Gany F, Senter L. Working with interpreters: an interactive Web‐based learning module. Acad Med. 2002;77(9):927.
Ikram UZ, Essink‐Bot ML, Suurmond J. How we developed an effective e‐learning module for medical students on using professional interpreters. Med Teach. 2015;37(5):422‐427.
Fune J, Chinchilla JP, Hoppe A, et al. Lost in translation: an OSCE‐based workshop for helping learners navigate a limited English proficiency patient encounter. MedEdPORTAL. 2021;17:11118.
Duraiswamy S, Rubin SJ, Kim Y, Mur T, Edwards HA. Limited English proficiency and head and neck cancer outcomes. Am J Otolaryngol. 2022;43(3):103470.
Calvillo‐Ortiz R, Polanco‐Santana JC, Castillo‐Angeles M, et al. Language proficiency and survival in pancreatic cancer: a propensity score‐matched analysis. J Gastrointest Surg. 2022;26(1):94‐103.
Duong LM, Singh SD, Buchanan N, Phillips JL, Gerlach K. Evaluation of primary/preferred language data collection. J Registry Manag. 2012;39(3):121‐132.
Rajaram A, Thomas D, Sallam F, Verma AA, Rawal S. Accuracy of the preferred language field in the electronic health records of two Canadian hospitals. Appl Clin Inform. 2020;11(4):644‐649.
Bernier R, Halpin E, Staffa SJ, Benson L, DiNardo JA, Nasr VG. Inclusion of non‐English‐speaking patients in research: a single institution experience. Pediatr Anesth. 2018;28(5):415‐420.
Brodeur M, Herrick J, Guardioloa J, Richman P. Exclusion of non‐English speakers in published emergency medicine research—a comparison of 2004 and 2014. Acta Inform Med. 2017;25(2):112‐115.
Anwar A, Dawson‐Hahn E, Lion KC, Jimenez ME, Yun K. Exclusion of families who speak languages other than English from federally funded pediatric trials. J Pediatr. 2023;262:113597.
Egleston BL, Pedraza O, Wong YN, et al. Characteristics of clinical trials that require participants to be fluent in English. Clin Trials. 2015;12(6):618‐626.
Coffin A, Elder B, Luercio M, et al. Creating culturally adapted multilingual materials for research. Pediatrics. 2024;154(1):e2023063988.